Ontology highlight
ABSTRACT: Aims/hypothesis
Imbalances in glucose metabolism are hallmarks of clinically silent prediabetes (defined as impaired fasting glucose and/or impaired glucose tolerance) representing dysmetabolism trajectories leading to type 2 diabetes. CD26/dipeptidyl peptidase 4 (DPP4) is a clinically proven molecular target of diabetes-controlling drugs but the DPP4 gene control of dysglycaemia is not proven.Methods
We dissected the genetic control of post-OGTT and insulin release responses by the DPP4 gene in a Portuguese population-based cohort of mainly European ancestry that comprised individuals with normoglycaemia and prediabetes, and in mouse experimental models of Dpp4 deficiency and hyperenergetic diet.Results
In individuals with normoglycaemia, DPP4 single-nucleotide var
SUBMITTER: Patarrao RS
PROVIDER: S-EPMC8960640 | biostudies-literature | 2022 May
REPOSITORIES: biostudies-literature